Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability.
Saved in:
| Title: | Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability. |
|---|---|
| Authors: | Ayyadevara VSSA; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA., Perencsik R; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.; University of British Columbia, Vancouver, BC, Canada., Patil S; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA., Gaur S; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA., Paik A; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.; Southern Adventist University, Collegedale, TN, USA., Toma M; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University Philadelphia, Philadelphia, PA, USA., Wertheim G; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Geng H; Department of Laboratory Medicine, University of California, San Francisco, CA, USA., Skorski T; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University Philadelphia, Philadelphia, PA, USA.; Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University Philadelphia, Philadelphia, PA, USA.; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Swaminathan S; Department of Systems Biology, City of Hope Beckman Research Institute, Duarte, CA, USA.; Department of Pediatrics, City of Hope Beckman Research Institute, Duarte, CA, USA., Hurtz C; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA. Churtz@llu.edu. |
| Source: | Leukemia [Leukemia] 2026 Aug; Vol. 40 (8), pp. 1824-1828. Date of Electronic Publication: 2026 Jun 30. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42380662 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ayyadevara+VSSA%22">Ayyadevara VSSA</searchLink>; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.<br /><searchLink fieldCode="AU" term="%22Perencsik+R%22">Perencsik R</searchLink>; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.; University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Patil+S%22">Patil S</searchLink>; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gaur+S%22">Gaur S</searchLink>; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.<br /><searchLink fieldCode="AU" term="%22Paik+A%22">Paik A</searchLink>; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.; Southern Adventist University, Collegedale, TN, USA.<br /><searchLink fieldCode="AU" term="%22Toma+M%22">Toma M</searchLink>; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wertheim+G%22">Wertheim G</searchLink>; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Geng+H%22">Geng H</searchLink>; Department of Laboratory Medicine, University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Skorski+T%22">Skorski T</searchLink>; Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University Philadelphia, Philadelphia, PA, USA.; Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University Philadelphia, Philadelphia, PA, USA.; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Swaminathan+S%22">Swaminathan S</searchLink>; Department of Systems Biology, City of Hope Beckman Research Institute, Duarte, CA, USA.; Department of Pediatrics, City of Hope Beckman Research Institute, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hurtz+C%22">Hurtz C</searchLink>; Department of Basic Science, Division of Cancer Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA. Churtz@llu.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2026 Aug; Vol. 40 (8), pp. 1824-1828. <i>Date of Electronic Publication: </i>2026 Jun 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42380662 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-026-03011-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1824 Titles: – TitleFull: Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ayyadevara VSSA – PersonEntity: Name: NameFull: Perencsik R – PersonEntity: Name: NameFull: Patil S – PersonEntity: Name: NameFull: Gaur S – PersonEntity: Name: NameFull: Paik A – PersonEntity: Name: NameFull: Toma M – PersonEntity: Name: NameFull: Wertheim G – PersonEntity: Name: NameFull: Geng H – PersonEntity: Name: NameFull: Skorski T – PersonEntity: Name: NameFull: Swaminathan S – PersonEntity: Name: NameFull: Hurtz C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2026 Aug Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 40 – Type: issue Value: 8 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |